121 related articles for article (PubMed ID: 3485680)
1. Natural and recombinant human interleukin 1-beta is cytotoxic for human melanoma cells.
Lachman LB; Dinarello CA; Llansa ND; Fidler IJ
J Immunol; 1986 Apr; 136(8):3098-102. PubMed ID: 3485680
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor and IL-1 associated with plasma membranes of activated human monocytes lyse monokine-sensitive but not monokine-resistant tumor cells whereas viable activated monocytes lyse both.
Ichinose Y; Bakouche O; Tsao JY; Fidler IJ
J Immunol; 1988 Jul; 141(2):512-8. PubMed ID: 3260254
[TBL] [Abstract][Full Text] [Related]
3. Human interleukin 1 is a cytocidal factor for several tumor cell lines.
Onozaki K; Matsushima K; Aggarwal BB; Oppenheim JJ
J Immunol; 1985 Dec; 135(6):3962-8. PubMed ID: 2415593
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxic liposomes: membrane interleukin 1 presented in multilamellar vesicles.
Bakouche O; Lachman LB; Knowles RD; Kleinerman ES
Lymphokine Res; 1988; 7(4):445-56. PubMed ID: 3264870
[TBL] [Abstract][Full Text] [Related]
5. Role of interleukin 1 in promoting human monocyte-mediated tumor cytotoxicity.
Onozaki K; Matsushima K; Kleinerman ES; Saito T; Oppenheim JJ
J Immunol; 1985 Jul; 135(1):314-20. PubMed ID: 3873493
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor as effector molecule in monocyte mediated cytotoxicity.
Ziegler-Heitbrock HW; Möller A; Linke RP; Haas JG; Rieber EP; Riethmüller G
Cancer Res; 1986 Nov; 46(11):5947-52. PubMed ID: 3756932
[TBL] [Abstract][Full Text] [Related]
7. Membrane-associated interleukin 1 alpha as a mediator of tumor cell killing by human blood monocytes fixed with paraformaldehyde.
Okubo A; Sone S; Tanaka M; Ogura T
Cancer Res; 1989 Jan; 49(2):265-70. PubMed ID: 2463072
[TBL] [Abstract][Full Text] [Related]
8. Role of interleukin 2 and a serum suppressive factor on the induction of activated killer cells cytotoxic for autologous human melanoma cells.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1985 Jul; 45(7):3173-8. PubMed ID: 3924397
[TBL] [Abstract][Full Text] [Related]
9. Synergism between human recombinant monocyte chemotactic and activating factor and lipopolysaccharide for activation of antitumor properties in human blood monocytes.
Singh RK; Fidler IJ
Lymphokine Cytokine Res; 1993 Oct; 12(5):285-91. PubMed ID: 8260537
[TBL] [Abstract][Full Text] [Related]
10. Growth-promoting effect of recombinant interleukin 1 and tumor necrosis factor for a human astrocytoma cell line.
Lachman LB; Brown DC; Dinarello CA
J Immunol; 1987 May; 138(9):2913-6. PubMed ID: 3494774
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor production by human monocytes is a regulated event: induction of TNF-alpha-mediated cellular cytotoxicity by endotoxin.
Kornbluth RS; Edgington TS
J Immunol; 1986 Oct; 137(8):2585-91. PubMed ID: 3760568
[TBL] [Abstract][Full Text] [Related]
12. Potent inhibition of interleukin 1 beta-mediated human melanoma (A375.6) lysis by corticosteroids, staurosporine, and tilorone.
Schultz RM; Howbert JJ; Archer RA
Immunopharmacol Immunotoxicol; 1989; 11(2-3):489-506. PubMed ID: 2621325
[TBL] [Abstract][Full Text] [Related]
13. [Induction of human monocyte-mediated tumor cell killing by alpha or beta interferon].
Utsugi T; Mutsuura S; Ogawara M; Shirahama T; Ishii K; Tsubura E; Sone S
Gan To Kagaku Ryoho; 1985 May; 12(5):1105-10. PubMed ID: 3994398
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin).
Dinarello CA
Year Immunol; 1986; 2():68-89. PubMed ID: 3107241
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 activation of cytotoxic T-lymphocytes infiltrating into human metastatic melanomas.
Itoh K; Tilden AB; Balch CM
Cancer Res; 1986 Jun; 46(6):3011-7. PubMed ID: 3486040
[TBL] [Abstract][Full Text] [Related]
16. Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes.
Peters PM; Ortaldo JR; Shalaby MR; Svedersky LP; Nedwin GE; Bringman TS; Hass PE; Aggarwal BB; Herberman RB; Goeddel DV
J Immunol; 1986 Oct; 137(8):2592-8. PubMed ID: 3760569
[TBL] [Abstract][Full Text] [Related]
17. Induction by interferon-alpha of tumoricidal activity of adherent mononuclear cells from human blood: monocytes as responder and effector cells.
Sone S; Utsugi T; Shirahama T; Ishii K; Mutsuura S; Ogawara M
J Biol Response Mod; 1985 Apr; 4(2):134-40. PubMed ID: 3998764
[TBL] [Abstract][Full Text] [Related]
18. B-cell line-derived interleukin 1 is cytotoxic for melanoma cells and promotes the proliferation of an astrocytoma cell line.
Bertoglio JH; Rimsky L; Kleinerman ES; Lachman LB
Lymphokine Res; 1987; 6(2):83-91. PubMed ID: 3495709
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of in vitro antitumor effects of interleukin 1 (IL 1).
Endo Y; Matsushima K; Oppenheim JJ
Immunobiology; 1986 Sep; 172(3-5):316-22. PubMed ID: 3492432
[TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
Chen AR; McKinnon KP; Koren HS
J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
